Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 571 | -1,169 | 77 | -63 | -183 |
| Other Working Capital | 811 | -636 | -138 | -289 | -551 |
| Other Operating Activity | 201 | 1,825 | -443 | -1,346 | -1,260 |
| Operating Cash Flow | $1,583 | $20 | $-504 | $-1,698 | $-1,994 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -58 | -4 | -23 | -33 |
| Other Investing Activity | 0 | 0 | 0 | 1 | 1 |
| Investing Cash Flow | $-13 | $-58 | $-4 | $-22 | $-32 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | -166 | -220 | -220 |
| Common Stock Issued | N/A | N/A | 700 | 23 | 3,313 |
| Other Financing Activity | -146 | -58 | 0 | 0 | -185 |
| Financing Cash Flow | $-146 | $-58 | $534 | $-197 | $2,908 |
| Exchange Rate Effect | -13 | -63 | 24 | -59 | 194 |
| Beginning Cash Position | 799 | 958 | 908 | 2,884 | 1,808 |
| End Cash Position | 2,210 | 799 | 958 | 908 | 2,884 |
| Net Cash Flow | $1,424 | $-96 | $26 | $-1,917 | $882 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,583 | 20 | -504 | -1,698 | -1,994 |
| Capital Expenditure | -13 | -58 | -4 | -23 | -33 |
| Free Cash Flow | 1,570 | -38 | -508 | -1,721 | -2,027 |